The influence of Gleason score ≤ 6 histology on the outcome of high-risk localized prostate cancer after modern radiotherapy
Abstract We aimed to retrospectively review outcomes in patients with high-risk prostate cancer and a Gleason score ≤ 6 following modern radiotherapy. We analyzed the outcomes of 1374 patients who had undergone modern radiotherapy, comprising a high-risk low grade [HRLG] group (Gleason score ≤ 6; n ...
Main Authors: | Hideya Yamazaki, Gen Suzuki, Koji Masui, Norihiro Aibe, Takuya Kimoto, Kei Yamada, Koji Okihara, Fumiya Hongo, Masayoshi Okumi, Takumi Shiraishi, Atsuko Fujihara, Ken Yoshida, Satoaki Nakamura, Takashi Kato, Yasutoshi Hashimoto, Haruumi Okabe |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-04-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-024-55457-z |
Similar Items
-
Role of Brachytherapy Boost in Clinically Localized Intermediate and High-Risk Prostate Cancer: Lack of Benefit in Patients with Very High-Risk Factors T3b–4 and/or Gleason 9–10
by: Hideya Yamazaki, et al.
Published: (2022-06-01) -
Novel Prognostic Index of High-Risk Prostate Cancer Using Simple Summation of Very High-Risk Factors
by: Hideya Yamazaki, et al.
Published: (2021-07-01) -
High-Dose-Rate Brachytherapy Monotherapy versus Image-Guided Intensity-Modulated Radiotherapy with Helical Tomotherapy for Patients with Localized Prostate Cancer
by: Hideya Yamazaki, et al.
Published: (2018-09-01) -
Radiotherapy for Clinically Localized T3b or T4 Very-High-Risk Prostate Cancer-Role of Dose Escalation Using High-Dose-Rate Brachytherapy Boost or High Dose Intensity Modulated Radiotherapy
by: Hideya Yamazaki, et al.
Published: (2021-04-01) -
Comparison of two high dose rate brachytherapy regimes
by: Gaurav Jaswal, et al.
Published: (2023-01-01)